Showing results (2541-2550 of 2,674) with videos related to
Sort By:
Pageof 268
Annals of the American Thoracic Society|September 13, 2013
Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesiaMargaret W Leigh, Milan J Hazucha, Kunal K Chawla, et al.Frontiers in Immunology|November 26, 2024
Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitisMohamed A Kamal, Matthew P Kosloski, Ching-Ha Lai, et al.Science (New York, N.Y.)|July 25, 2009
Knockout rats via embryo microinjection of zinc-finger nucleasesAron M Geurts, Gregory J Cost, Yevgeniy Freyvert, et al.BMJ Open|October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 studyThomas D Norton, Mazhar Thakur, Samit Ganguly, et al.Nature|February 15, 2023
Suppressed basal melting in the eastern Thwaites Glacier grounding zonePeter E D Davis, Keith W Nicholls, David M Holland, et al.Cells|September 26, 2025
ODAD4-Related Primary Ciliary Dyskinesia: Report of Five Cases and a Founder Variant in QuebecMarie-Hélène Bourassa, Guillaume Sillon, Shuizi Ding, et al.Cancer Immunology Research|January 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial CancerMatthew D Galsky, Mark Kockx, Juliette Roels, et al.Science Translational Medicine|February 7, 2020
APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloidNa Zhao, Olivia N Attrebi, Yingxue Ren, et al.Journal of Neurotrauma|October 29, 2020
Blood Biomarkers for Detection of Brain Injury in COVID-19 PatientsSteven T DeKosky, Patrick M Kochanek, Alex B Valadka, et al.Contemporary Clinical Trials|September 20, 2021
RAMPART: A model for a regulatory-ready academic-led phase III trial in the adjuvant renal cell carcinoma settingAngela Meade, Bhavna Oza, Eleni Frangou, et al.Pageof 268